9 results
10-K
2020 FY
NEXI
Neximmune Inc
31 Mar 21
Annual report
4:02pm
, manufacturing, regulatory and commercial functions. If NEXI-001, NEXI-002 or any of our future product candidates do not offer sustainable advantages … for product candidates for which we complete clinical trials;
developing a sustainable and scalable manufacturing process for our product candidates
424B4
NEXI
Neximmune Inc
16 Feb 21
Prospectus supplement with pricing info
4:38pm
trials;
developing a sustainable and scalable manufacturing process for our product candidates, including establishing and maintaining commercially viable … not be sustainable. As a result of these and other factors, you may be unable to resell your shares of our common stock at or above the initial public
S-1/A
ddjdkiworgmhimp2
8 Feb 21
IPO registration (amended)
7:29am
S-1
qkg0ye szo6d0jdr4vtj
19 Jan 21
IPO registration
4:38pm
DRS/A
qe0ffc6ia
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
pi67h 2ylw2kc00t
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next